Publications by authors named "Ralph P Insinga"

Claim this Profile
C
Cost-effectiveness analysis of pembrolizumab as an adjuvant treatment of early-stage non-small cell lung cancer following complete resection and platinum-based chemotherapy in Canada.
Sylvi Nguyen, Elizabeth Wehler, Chloe Langevin, Arielle Bensimon, Natasha B Leighl, Ralph P Insinga

J Med Econ· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of pembrolizumab + chemotherapy versus chemotherapy and pembrolizumab monotherapy in first line treatment of NSCLC in the US - updated analyses with additional trial follow-up.
Ralph P Insinga, Josephine L Feliciano, Nan Qiao, Kristel Vandormael, Ying Zhang

J Med Econ· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In response to She et al., "Cost-effectiveness analysis of pembrolizumab versus chemotherapy as first-line treatment in locally advanced or metastatic non-small cell lung cancer with PD-L1 tumor proportion score 1% or greater".
Min Huang, Ralph P Insinga, Thomas Burke, Ying Zhang, Gilberto de Lima Lopes

Lung Cancer· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost Effectiveness of PD-L1-Based Test-and-Treat Strategy with Pembrolizumab as the First-Line Treatment for Metastatic NSCLC in Hong Kong.
Herbert H Loong, Carlos K H Wong, Linda Kam Suet Leung, Praveen Dhankhar, Ralph P Insinga

Pharmacoecon Open· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of pembrolizumab versus chemotherapy as first-line treatment in PD-L1-positive advanced non-small-cell lung cancer in the USA.
Min Huang, Gilberto de Lima Lopes, Ralph P Insinga, Thomas Burke, Flavia Ejzykowicz

Immunotherapy· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of pembrolizumab in combination with chemotherapy versus chemotherapy and pembrolizumab monotherapy in the first-line treatment of squamous non-small-cell lung cancer in the US.
Ralph P Insinga, David J Vanness, Josephine L Feliciano, Kristel Vandormael, Sory Traore

Curr Med Res Opin· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of pembrolizumab in combination with chemotherapy in the 1st line treatment of non-squamous NSCLC in the US.
Ralph P Insinga, David J Vanness, Josephine L Feliciano, Kristel Vandormael, Sory Traore

J Med Econ· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness Analysis of Golimumab in the Treatment of Non-Radiographic Axial Spondyloarthritis in Scotland.
Rebekah H Borse, Sumesh Kachroo, Chloe Brown, Eilish McCann, Ralph P Insinga

Rheumatol Ther· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A discrete event simulation model of clinical and operating room efficiency outcomes of sugammadex versus neostigmine for neuromuscular block reversal in Canada.
Ralph P Insinga, Cédric Joyal, Alexandra Goyette, André Galarneau

BMC Anesthesiol· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EQ-5D™-derived utility values for different levels of migraine severity from a UK sample of migraineurs.
Megan R Stafford, Asha Hareendran, Daisy S Ng-Mak, Ralph P Insinga, Ruifeng Xu

Health Qual Life Outcomes· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Costs associated with outpatient, emergency room and inpatient care for migraine in the USA.
Ralph P Insinga, Daisy S Ng-Mak, Mary E Hanson

Cephalalgia· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age-based programs for vaccination against HPV.
Elamin H Elbasha, Erik J Dasbach, Ralph P Insinga, Richard M Haupt, Eliav Barr

Value Health· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EuroQol (EQ-5D) health utility scores for patients with migraine.
Ruifeng Xu, Ralph P Insinga, Wendy Golden, X Henry Hu

Qual Life Res· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incident cervical HPV infections in young women: transition probabilities for CIN and infection clearance.
Ralph P Insinga, Gonzalo Perez, Cosette M Wheeler, Laura A Koutsky, Suzanne M Garland

Cancer Epidemiol Biomarkers Prev· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence, duration, and reappearance of type-specific cervical human papillomavirus infections in young women.
Ralph P Insinga, Gonzalo Perez, Cosette M Wheeler, Laura A Koutsky, Suzanne M Garland

Cancer Epidemiol Biomarkers Prev· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incremental 1-year medical resource utilization and costs for patients with herpes zoster from a set of US health plans.
Ronald R White, Greg Lenhart, Puneet K Singhal, Ralph P Insinga, Robbin F Itzler

Pharmacoeconomics· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and costs of cervical intraepithelial neoplasia in a US commercially insured population.
Henry J Henk, Ralph P Insinga, Puneet K Singhal, Theodore Darkow

J Low Genit Tract Dis· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The cost-effectiveness of a quadrivalent human papillomavirus vaccine in Taiwan.
Erik J Dasbach, Ralph P Insinga, Yuh Cheng Yang, Raoh-Fang Pwu, Christina Lac

Asian Pac J Cancer Prev· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing incidence and economic burden of genital warts with data from a US commercially insured population.
Tracey Hoy, Puneet K Singhal, Vincent J Willey, Ralph P Insinga

Curr Med Res Opin· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiologic natural history and clinical management of Human Papillomavirus (HPV) Disease: a critical and systematic review of the literature in the development of an HPV dynamic transmission model.
Ralph P Insinga, Erik J Dasbach, Elamin H Elbasha

BMC Infect Dis· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human papillomavirus infections and vulvar disease development.
Suzanne M Garland, Ralph P Insinga, Heather L Sings, Richard M Haupt, Elmar A Joura

Cancer Epidemiol Biomarkers Prev· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A review of health-utility data for osteoarthritis: implications for clinical trial-based evaluation.
Hirsch S Ruchlin, Ralph P Insinga

Pharmacoeconomics· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthcare resource use and costs associated with cervical, vaginal and vulvar cancers in a large U.S. health plan.
Ralph P Insinga, Xin Ye, Puneet K Singhal, George W Carides

Gynecol Oncol· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multi-type HPV transmission model.
Elamin H Elbasha, Erik J Dasbach, Ralph P Insinga

Bull Math Biol· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural differences among cost-effectiveness models of human papillomavirus vaccines.
Ralph P Insinga, Erik J Dasbach, Elamin H Elbasha

Expert Rev Vaccines· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis